SGLT2 inhibition reprograms systemic metabolism via FGF21-dependent and -independent mechanisms

Soravis Osataphan(Joslin Diabetes Center), Mary‐Elizabeth Patti(Joslin Diabetes Center)
JCI Insight
March 6, 2019
Cited by 227


Related Papers